Michael Wheeler is a Professor in Philosophy at the University of Stirling, focusing on cognitive science, phenomenology, and the philosophy of technology. His work bridges existentialist philosophy with modern AI ethics and embodied cognition. Key Research Themes: Extended mind, distributed cognition, and transparency in smart machines. Recent Projects: Explore the societal impact of AI, cognitive change in the arts, and the interplay between aging and cognition. Selected Articles (2024-2019): His publications span topics like creativity and contingency in the arts, transparency in AI, and the evolutionary psychology of reasoning. Notable Contributions: Advocates for integrating phenomenology into cognitive science and challenges representationalist frameworks in AI and robotics.
David N. Ku is the Lawrence P. Huang Endowed Chair for Engineering Entrepreneurship and Regents' Professor at Georgia Institute of Technology. He holds appointments in the School of Mechanical Engineering (Woodruff School) within the College of Engineering. His research focuses on biofluid mechanics, medical device innovation, and translational technology, with emphasis on thrombosis mechanisms and vascular diseases. Education: M.D. from Emory University (1984); Ph.D. and M.S. from Georgia Tech (1983, 1982); B.A. from Harvard University (1978). Research interests include unsteady fluid dynamics in vascular systems, nanoparticle medical devices for thrombosis prevention, and porous thrombus applications for hemostasis. His work bridges bioengineering with entrepreneurship, teaching product development at the Business School and collaborating with Emory University, Paris Tech-Mines, and ETH Zurich. Key awards include the American Institute for Medical and Biological Engineering Fellowship, DLA Piper Inventor of the Year, and NSF Presidential Young Investigator Award. His research is funded by NIH, NSF, and industry partners. Labs/Teams: Leads a lab using microfluidics and computational mechanics for vascular disease solutions. Collaborates on technologies to address post-partum hemorrhage and traumatic bleeding.
Jennifer Lewis is the Hansjorg Wyss Professor of Biologically Inspired Engineering and Jianming Yu Professor of Arts and Sciences at Harvard University's Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). Her research focuses on bioengineering, materials science, and advanced manufacturing, with emphasis on 3D-printed functional materials, organoids, and soft robotics. She leads the Lewis Research Group, which develops biomimetic technologies for regenerative medicine, energy systems, and robotics. Lewis holds appointments in SEAS, the Department of Chemistry and Chemical Biology, and the Wyss Institute for Biologically Inspired Engineering. Her research areas include applied mathematics, fluid mechanics, soft matter physics, and bioengineering applications such as kidney organoid models, vascularized tissues, and programmable materials. Notable innovations include kidney organoid-on-chip systems for drug testing, 3D-printed liquid crystal elastomers, and bioprinted cardiac tissues. Lewis was awarded the 2025 James Prize in Science and Technology Integration for pioneering interdisciplinary research. Her lab's projects span organ building blocks, immune-response modeling in transplanted tissues, and acoustophoretic printing techniques for high-resolution bioprinting. Collaborations include the NIH Somatic Cell Genome Editing Program and industry partnerships for bioprosthetic valve research. She advises on grants totaling over $20M and mentors a multidisciplinary team of postdocs and graduate students in materials science, biomedical engineering, and mechanical engineering. Lewis' lab facilities include the Pierce Hall lab (Cambridge) and Allston SEAS campus, with state-of-the-art 3D printing systems, microfluidics platforms, and bioreactors for organoid culture. Current projects aim to engineer functional human tissues for therapeutic applications and develop smart materials with programmable mechanical/chemical responses.
Meng Li is the Noah Harding Associate Professor of Statistics at Rice University's School of Engineering. He specializes in Bayesian analysis, machine learning, and statistical theory. His research bridges methodological development and applications in biomedical sciences, materials informatics, and neuroimaging. Li holds a Ph.D. from North Carolina State University and a B.S. from Sun Yat-sen University. He has been recognized with awards including the 2020 Rice Engineering Excellence Award and the Ralph E. Powe Junior Faculty Enhancement Award. Li's research focuses on probabilistic modeling of complex data such as images, functional data, and networks. His funded projects include AI frameworks for pancreatic cancer biomarkers and Bayesian spatiotemporal modeling of marine ecosystems. He collaborates with institutions like Houston Methodist and Baylor College of Medicine on medical applications. His teaching includes advanced courses like Bayesian Statistics and Advanced Bayesian Inference. He advises over 30 students, many of whom have pursued academic and industry roles. Li serves as an associate editor for Bayesian Analysis and the new ACM Transactions on Probabilistic Machine Learning.
Giuseppe Rizzo is a Full Professor at the Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome. His academic career focuses on Maternal Fetal Medicine, with expertise in ultrasound applications, fetal growth restriction, preeclampsia, and congenital anomalies. Research Interests : Delivery optimization, prematurity prediction, ultrasound diagnostics, and placental anomalies. Recent Publications : Over 15 high-impact studies in 2024-2025 on topics like umbilical cord abnormalities, cerebroplacental ratios, and gestational diabetes complications. Clinical Expertise : Prenatal counseling, Doppler ultrasound, and labor management protocols. Collaborations : Active in multicenter trials across Italy and Europe, with a focus on fetal neurosonology and high-fidelity obstetric simulation.
Prof. Dr.-Ing. Lars Linsen is a full Professor of Computer Science at the Westfälische Wilhelms-Universität (WWU) Münster, leading the VISualization & graphIX (VISIX) group. His primary affiliation is the Institute of Computer Science within the Faculty of Mathematics and Computer Science. He holds adjunct professorships at Jacobs University, Bremen, and has held previous academic roles including Full Professor at Jacobs University (2012–2017) and Associate/Assistant Professor roles in Germany and the U.S. His research focuses on interactive visual analysis, medical visualization, and scientific visualization, with applications in life sciences and engineering. Education: PhD (Dr.-Ing.) in Computer Science from Universität Karlsruhe (2001), M.Sc. (Diplom) in Computer Science (1997), B.Sc. (Vordiplom) in Computer Science (1994). Awards: IEEE Visualization Design Contest Winner (2008, 2022, 2018), Preis des Fördervereins des Forschungszentrum Informatik (2002). Research Highlights: Develops visualization tools for medical imaging (e.g., mass spectrometry imaging, MRI data analysis) and physical simulations (e.g., wildfire spread analysis, asteroid impact modeling). Active in EU-funded projects like Pig-Pro-QuO (surface coatings) and cells-in-motion initiatives. Supervised over 20 PhD/MS advisees, including notable graduates in medical visualization and simulation ensemble analysis. Publications: Over 100 peer-reviewed articles in top venues like IEEE Transactions on Visualization and Computer Graphics, Computers & Graphics, and EuroVis. Key works include SciVis contest-winning wildfire analysis frameworks and medical visualization tools for stenosis detection. Teaching: Offers courses on visualization, computer graphics, and computational science. Actively involved in thesis supervision and curriculum development at both WWU Münster and Jacobs University. Grants & Collaborations: Principal investigator on DFG-funded projects (e.g., hemodynamics simulations, ensemble visualization) and industry collaborations (e.g., Tascon GmbH for coating quality analysis). Member of the Cells-in-Motion Interfaculty Centre and CDH board at WWU.
Michel Versluis is a Full Professor at the University of Twente, Netherlands, specializing in Physical and Medical Acoustics within the Physics of Fluids group. His work focuses on microbubbles and microdroplets for medical imaging and therapy, as well as microfluidic applications in medicine and nanotechnology. University of Twente, Physics of Fluids group His research bridges physics and biomedical engineering, with publications in high-impact journals like PNAS and IEEE Transactions. Recent work emphasizes ultrasound-driven microbubble dynamics, additive manufacturing of flow phantoms, and deep learning for super-resolution imaging. 2025 publications: vascular phantoms, PROTEUS simulator, acoustic microbubble control 2024 innovations: 3D-printed medical devices, immunogenic cell death optimization Contact: m.versluis@utwente.nl
Meisam Asgari is an Assistant Professor in the Department of Medical Engineering at the University of South Florida. He holds a Ph.D. in Mechanical Engineering from McGill University (2015), with postdoctoral training at Northwestern University (2018–2020) and McGill University (2016–2018). His research focuses on biomechanics, cardiovascular diseases, biomimetic design, and functional gradients in biological materials. He teaches courses such as Transport Phenomena in Biomedical Engineering and Biomechanics. Education: Ph.D. Mechanical Engineering, McGill University, 2015 M.Sc. Solid Mechanics, Isfahan University of Technology, 2011 B.Sc. Mechanical Engineering, Isfahan University of Technology, 2007 Awards: NSERC Postdoctoral Fellowship (2018–2020) McGill Engineering International Tuition Award (2011–2014) Outstanding Teaching Assistant Award, McGill (2015) His research integrates experimental and computational methods to study vascular diseases, biomaterials for tissue engineering, and structural adaptations in biological systems like crustacean exoskeletons. Recent work includes developing decellularized aortic grafts and investigating collagen mechanics in diseased tissues. Publications span Acta Biomaterialia , Scientific Reports , and Journal of the Mechanical Behavior of Biomedical Materials , emphasizing biomechanics and material characterization. His work bridges engineering and biology to address clinical challenges in cardiovascular and musculoskeletal systems.
Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.
Dr. Anagha Vaze is a Clinical Lecturer affiliated with the University of Sydney's Faculty of Medicine and Health (FMH) and the Save Sight Institute. Her expertise lies in ophthalmology, with a focus on retinal disorders, diabetic eye diseases, and clinical research. She has contributed to studies on VEGF inhibitors, corticosteroid delivery platforms for macular edema, and the application of genomics in retinal diagnostics. Research Interests: Retinal degeneration and vascular abnormalities Management strategies for diabetic retinopathy and macular telangiectasia Clinical outcomes of anti-VEGF therapies Infectious diseases in immunocompromised patients (e.g., heart transplant recipients) Her publications (2014–2022) emphasize observational studies, drug delivery innovations, and case reports on rare infections. Key contributions include assessing treatment discontinuation protocols for neovascular AMD and exploring photobiomodulation for diabetic macular edema. While no scientific awards or grants are explicitly listed, her work reflects active engagement in clinical research and patient care. She is part of the Save Sight Institute, a prominent research center within the FMH, focusing on vision science and ophthalmic advancements.
Mihir Gupta, MD, is an Assistant Professor of Neurosurgery at Yale School of Medicine. As a fellowship-trained spine surgeon with dual expertise in neurosurgery and orthopedics, he performs both traditional and minimally invasive procedures for complex spinal disorders including degenerative conditions, deformities, tumors, infections, and trauma-related issues. Dr. Gupta also specializes in revision spine surgeries for patients with persistent or new problems following previous operations. Dr. Gupta's educational background includes a BA from Harvard College, an MD from Stanford University School of Medicine, neurosurgical residency at the University of California San Diego, postdoctoral studies at Harvard Medical School, and an orthopedic spine surgery fellowship at Johns Hopkins University. His clinical philosophy emphasizes understanding each patient's unique story through thorough evaluation and physical examination before developing personalized treatment plans. His research interests focus on understanding how genetics contribute to different spinal disorders and how care can be personalized. Dr. Gupta's publications demonstrate expertise across multiple domains including brain tumor diagnostics (particularly CNS lymphoma and glioblastoma), spine surgery outcomes, gender diversity in academic medicine, and neuroimmunology. His work often bridges clinical practice with molecular diagnostics, emphasizing rapid testing methods that accelerate treatment decisions for brain tumor patients. Dr. Gupta collaborates extensively with multidisciplinary teams including physical therapists, pain management specialists, anesthesiologists, and interventional radiologists to develop comprehensive treatment approaches. He emphasizes that surgery is often the last resort, prioritizing nonsurgical options when appropriate. His clinical work at Yale Medicine focuses on highly personalized spine procedures using advanced robotics, navigation, and minimally invasive techniques to tailor solutions for individual patients.
Matthew B Potts, MD is an Associate Professor in the Department of Neurological Surgery at Northwestern University's Feinberg School of Medicine, with secondary appointments in Neurology (Ken and Ruth Davee Department) and Radiology. His clinical expertise spans cerebrovascular surgery, neurointerventional/endovascular procedures, and management of brain aneurysms, vascular malformations, stroke, and spinal vascular disease across multiple Northwestern Medicine hospitals including Shirley Ryan AbilityLab. Dr. Potts completed his BS at MIT (2000) and MD at UCSF (2007), followed by surgical internship (2008), neurological surgery residency (2013), and cerebrovascular fellowship at NYU (2015). BS: Massachusetts Institute of Technology (2000) MD: University of California, San Francisco (2007) Internship: University of California-San Francisco Medical Center, Surgery (2008) Residency: University of California-San Francisco Medical Center, Neurological Surgery (2013) Fellowship: New York University Medical Center, Endovascular/Cerebrovascular Surgery (2015) His research program centers on chronic subdural hematoma pathophysiology, emergency stroke thrombectomy process optimization, and aneurysm treatment outcomes. He employs clinical-translational approaches to improve cerebrovascular disease management through advanced surgical techniques and rigorous outcomes assessment. Recent 2025 publications reveal strong focus on hydrocephalus diagnostics, hematoma expansion biomarkers, vertebrobasilar anatomy, and dolichoectatic aneurysm natural history. These works demonstrate multidisciplinary collaboration across neurosurgery, neurology, and radiology to advance diagnostic precision and treatment efficacy in complex cerebrovascular disorders. Dr. Potts has received exceptional recognition for medical education, including three consecutive Outstanding Teacher Awards (2019-2021) and the John X. Thomas, Jr. Best Teachers Award (2020). His research contributions are honored by the NIH Rush L. Kirschstein Award (2012) and Howard Hughes Fellowship (2005). Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2021) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) John X. Thomas, Jr. Best Teachers of Feinberg Award, Northwestern University Feinberg School of Medicine (2020) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2019) Ivan Ciric Resident Teaching Award, Northwestern University Department of Neurological Surgery (2017) Best Scientific Presentation, UCSF Department of Neurological Surgery (2013) NIH Rush L. Kirschstein National Research Service Award, National Institutes of Health (2012) UCSF School of Medicine Alumni Scholarship Award, University of California, San Francisco (2006) Howard Hughes Medical Institute Medical Student Research Fellow, Howard Hughes Medical Institute (2005) UCSF Quarterly Research Fellowship, University of California, San Francisco (2005) MIT-Germany Program Research Fellowship, Massachusetts Institute of Technology (2001) As an educator, Dr. Potts mentors medical students and residents through Feinberg's neurological surgery program, evidenced by his resident teaching award. His research is supported by institutional resources and prior NIH funding, with current industry relationships including ownership in Rhaeos, Inc. He serves as Assistant Editor for Neurosurgery and Associate Editor for Operative Neurosurgery. He operates within Northwestern's integrated neurovascular team across multiple hospital sites, collaborating with neurologists, neuroradiologists, and rehabilitation specialists to deliver comprehensive care for complex cerebrovascular conditions, with ongoing work focused on improving health equity in stroke treatment and minimally invasive surgical innovation.
Virend Somers, M.D., Ph.D. , is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, with primary appointments in the Department of Cardiovascular Medicine, and joint appointments in Physiology & Biomedical Engineering and Nephrology & Hypertension. He directs the Cardiovascular and Sleep Facilities within Mayo Clinic's Center for Clinical and Translational Science. Education: MB ChB, University of Natal D.Phil., University of Oxford Resident, Internal Medicine, University of Iowa Fellow, Cardiovascular Diseases, University of Iowa Hospitals and Clinics Research Interests: Dr. Somers' research centers on neural and vascular mechanisms in circulatory control, particularly in sleep disorders such as obstructive and central sleep apnea, hypertension, obesity, and heart failure. His team investigates autonomic nervous system regulation, chemoreflex responses, and vascular biology in humans. His work bridges basic physiology with clinical applications to improve cardiovascular outcomes. Publication Trends: His recent publications (2021–2025) show a strong emphasis on sleep-cardiovascular interactions, including blood pressure regulation during sleep, cardiovascular mortality in the context of comorbidities like obesity and COVID-19, and neurocardiological mechanisms in arrhythmias and syncope. His work frequently appears in high-impact journals such as Sleep , Journal of the American Heart Association , and Journal of Physiology . Scientific Awards: Alice Sheets Marriott Professor (2016) CTSA Mentor of the Year (2012) Distinguished Scientist in Cardiopulmonary Physiology, American College of Chest Physicians (2017) Stanford University World's Top 2% Scientists (2021) Lifetime Achievement Award, South African Society of Sleep Medicine (2012) Doctor Honoris Causa, Masaryk University (2007) Advising and Grants: Dr. Somers has mentored numerous trainees who have won national awards. His research is supported by four NIH R01 grants, a Dana Foundation grant, and a NATO grant. His leadership in collaborative research spans institutions in the U.S., Europe, and South Africa. Labs and Teams: He leads the Cardiovascular Facility and Sleep Facility at Mayo Clinic’s Center for Clinical and Translational Science, fostering interdisciplinary research on sleep and cardiovascular disease.
Prof. Robbert Jan Kok is a Professor of Drug Delivery Technology at Utrecht University's Utrecht Institute for Pharmaceutical Sciences (UIPS) and Programme Director for the Bachelor of Pharmacy. He obtained his Pharmacy degree (1993) and PhD in renal drug targeting (1998) from the University of Groningen, followed by postdoctoral research on endothelial-targeted drug delivery. His work spans curriculum development for pharmacy programs and interdisciplinary research in drug innovation. Research Focus: Kok specializes in advanced drug delivery systems, including nanomedicines for kinase inhibitors, 3D-printed formulations, and stimuli-responsive carriers. Key areas include: Targeted delivery to tumors, kidneys, and inflamed tissues Polymeric micelles, liposomes, and microspheres for sustained release Biopharmaceutics and pharmacokinetic optimization Publication Trends: His recent work emphasizes nanotechnology-enabled therapies (e.g., curcumin nanodelivery, photodynamic micelles) and device-integrated drug release (3D-printed implants, macroencapsulation). Studies frequently combine material science with preclinical validation in cancer, renal diseases, and inflammatory disorders. Academic Leadership: Kok oversees student advising, laboratory operations, and international collaborations at UIPS. His team explores translational applications of drug delivery platforms, including partnerships for vascularized tissue engineering and combination therapies.
Privatdozent Dr. Andreas Faust is a leading researcher at the European Institute for Molecular Imaging (EIMI) at the University of Münster, where he heads the Chemical Targeting Lab. His work focuses on developing innovative imaging agents for medical diagnostics, particularly in radiopharmaceutical chemistry and molecular imaging. He maintains strong affiliations with the Department of Nuclear Medicine at the University Hospital Münster and participates in the "Cells in Motion" excellence cluster, contributing to cutting-edge research at the intersection of chemistry, medicine, and imaging technology. Dr. Faust completed his chemistry studies at the University of Münster, earning his Diploma in 1999, followed by his doctoral degree (Dr. rer. nat.) in 2003 with research on artificial caffeine receptors. His academic journey continued with positions at the Department of Organic Chemistry and the Department of Nuclear Medicine before becoming head of the chemistry group at EIMI in 2011. Dr. Faust's research centers on organic and medicinal chemistry with specialization in radiopharmaceutical chemistry . His team develops novel tracers for diagnostic molecular imaging using positron emission tomography (PET), single-photon emission computed tomography (SPECT), optical imaging, and photoacoustic imaging. A significant portion of his work focuses on creating specific ligands for the alarmins S100A8/S100A9 and bacteria-specific tracers based on complex carbohydrates or siderophores. His research has important applications in inflammation imaging, infection diagnostics, and cancer theranostics, with emphasis on improving metabolic stability and target specificity of imaging agents. His publication record demonstrates consistent contributions to molecular imaging, with recent work emphasizing bacteria-specific PET tracers, inflammation imaging targeting S100 proteins, and novel optical imaging probes. The research shows a clear trajectory toward developing clinically applicable imaging agents with improved specificity and metabolic stability, particularly in the areas of infection diagnostics and inflammation monitoring. 2017: Best Poster Award at Symposium "Molecular Imaging Agents in Medicine," Groningen 2009: Young Investigator Award at Deutscher Röntgenkongress, Berlin 2005: Best Scientific Poster Award at 4th Annual Meeting of the Society of Molecular Imaging, Köln Dr. Faust leads multiple significant research projects, including as Coordinator of a project on immune cell distribution imaging (2019-2024) and as Principal Investigator for CRC-project A03 "Targeting of S100A8/A9 for imaging of inflammatory disorders" and research on vascular graft infections (both 2021-2024). His Chemical Targeting Lab comprises a multidisciplinary team working at the intersection of chemistry, microbiology, and medical imaging, securing substantial funding from the Innovative Medicines Initiative and DFG Collaborative Research Centre. The Chemical Targeting Lab maintains state-of-the-art facilities for chemical synthesis, radiochemistry, and biological testing. The lab collaborates extensively with microbiologists, clinicians, and imaging specialists to translate basic research into clinical applications. Current research directions include optimizing bacterial imaging probes for clinical diagnostics and developing new inflammation-specific tracers for early disease detection, with particular focus on S100A9-targeted imaging and siderophore-based bacterial detection systems.
